Does administration of vaginal estrogens increase the risk of venous thromboembolism: A case–control study

Svendsen, Andreas Ludvig Ohm; Esbech, Peter Skov; Hallas, Jesper; Lund, Lars Christian

doi:10.1111/bcpt.13644

Search citation statements

Order By: Relevance

Paper Sections

Select...

Thrombosis Risk Based On Hormone Therapy Indication1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…HT is available in oral, transdermal, and intravaginal forms. Transdermal and intravaginal forms of estradiol are associated with a lower risk of VTE compared to oral formulations, although a decision about individual use may be based on underlying cardiovascular health [ [28] , [29] , [30] ]. Mobile app decision aids can be helpful for this evaluation, are based on assessment of underlying cardiovascular risk, and take into account the time since menopause, symptom profile, and cancer [ 31 , 32 ].…”

Section: Thrombosis Risk Based On Hormone Therapy Indicationmentioning

confidence: 99%